Global sensitivity analysis of biological multiscale models

M Renardy, C Hult, S Evans, JJ Linderman… - Current opinion in …, 2019 - Elsevier
Mathematical models of biological systems need to both reflect and manage the inherent
complexities of biological phenomena. Through their versatility and ability to capture …

Multi-method global sensitivity analysis of mathematical models

A Dela, B Shtylla, L de Pillis - Journal of Theoretical Biology, 2022 - Elsevier
Increasingly-sophisticated parameter-sensitivity analysis techniques continue to be
developed, and each technique comes with its own set of advantages and disadvantages …

The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease

RT Bishop, AK Miller, M Froid, N Nerlakanti, T Li… - Nature …, 2024 - nature.com
Multiple myeloma (MM) is an osteolytic malignancy that is incurable due to the emergence of
treatment resistant disease. Defining how, when and where myeloma cell intrinsic and …

Evaluation framework for systems models

S Braakman, P Pathmanathan… - CPT: pharmacometrics & …, 2022 - Wiley Online Library
As decisions in drug development increasingly rely on predictions from mechanistic systems
models, assessing the predictive capability of such models is becoming more important …

Mathematical modelling and analysis to study the impact of mining on natural interactive dynamics between plants and carbon dioxide

A Tandon - Modeling Earth Systems and Environment, 2023 - Springer
A mathematical model is formulated to delve into the changes that have been produced on
the natural interactive dynamics between plants and carbon dioxide when mining intervenes …

A validated mathematical model of FGFR3‐mediated tumor growth reveals pathways to harness the benefits of combination targeted therapy and immunotherapy in …

K Okuneye, D Bergman, JC Bloodworth… - Computational and …, 2021 - Wiley Online Library
Bladder cancer is a common malignancy with over 80,000 estimated new cases and nearly
18,000 deaths per year in the United States alone. Therapeutic options for metastatic …

On modeling the synergy of Cancer immunotherapy with radiotherapy

U Ledzewicz, H Schättler - … in Nonlinear Science and Numerical Simulation, 2023 - Elsevier
The release of tumor antigens during traditional cancer treatments (such as chemo-or
radiotherapy) can lead to a stimulation of the immune response which provides synergistic …

[HTML][HTML] Determining optimal combination regimens for patients with multiple myeloma

M Aghaee, U Ledzewicz, M Robbins, N Bezman… - European Journal of …, 2023 - Elsevier
While many novel therapies have been approved in recent years for treating patients with
multiple myeloma, there is still no established curative regimen, especially for patients with …

The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous proteasome inhibitor resistant disease

RT Bishop, AK Miller, M Froid, N Nerlakanti, T Li… - bioRxiv, 2022 - biorxiv.org
Multiple myeloma (MM) is an osteolytic plasma cell malignancy that, despite being
responsive to therapies such as proteasome inhibitors, frequently relapses. Understanding …

A Role of Effector CD T Cells Against Circulating Tumor Cells Cloaked with Platelets: Insights from a Mathematical Model

KJ Mahasa, R Ouifki, L de Pillis, A Eladdadi - Bulletin of Mathematical …, 2024 - Springer
Cancer metastasis accounts for a majority of cancer-related deaths worldwide. Metastasis
occurs when the primary tumor sheds cells into the blood and lymphatic circulation, thereby …